BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18657803)

  • 1. Windows based general PBPK/PD modeling software.
    Luecke RH; Pearce BA; Wosilait WD; Doerge DR; Slikker W; Young JF
    Comput Biol Med; 2008 Sep; 38(9):962-78. PubMed ID: 18657803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal growth considerations for PBPK modeling.
    Luecke RH; Pearce BA; Wosilait WD; Slikker W; Young JF
    J Toxicol Environ Health A; 2007 Jun; 70(12):1027-37. PubMed ID: 17497414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A delayed nonlinear PBPK model for genistein dosimetry in rats.
    Zager MG; Schlosser PM; Tran HT
    Bull Math Biol; 2007 Jan; 69(1):93-117. PubMed ID: 17024552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.
    Zhang Y; Huo M; Zhou J; Xie S
    Comput Methods Programs Biomed; 2010 Sep; 99(3):306-14. PubMed ID: 20176408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ growth functions in maturing male Sprague-Dawley rats.
    Mirfazaelian A; Kim KB; Lee S; Kim HJ; Bruckner JV; Fisher JW
    J Toxicol Environ Health A; 2007 Mar; 70(5):429-38. PubMed ID: 17454567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
    Farenc C; Fabreguette JR; Bressolle F
    Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a feature of regression disturbance on the efficiency of fitting growth curves.
    Pasternak H; Shalev BA
    Growth Dev Aging; 1994; 58(1):33-9. PubMed ID: 8077080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
    Pereira LM; Maya MT; Morais JA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic modeling of nanoparticles.
    Li M; Al-Jamal KT; Kostarelos K; Reineke J
    ACS Nano; 2010 Nov; 4(11):6303-17. PubMed ID: 20945925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro measurements of metabolism for application in pharmacokinetic modeling.
    Lipscomb JC; Poet TS
    Pharmacol Ther; 2008 Apr; 118(1):82-103. PubMed ID: 18374419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative explicit model expression equivalent to the integrated michaelis-menten equation and its application to nonlinear saturation pharmacokinetics.
    Goličnik M
    Ther Drug Monit; 2011 Jun; 33(3):362-5. PubMed ID: 21516057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proper lumping in systems biology models.
    Dokoumetzidis A; Aarons L
    IET Syst Biol; 2009 Jan; 3(1):40-51. PubMed ID: 19154083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
    Bouzom F; Ball K; Perdaems N; Walther B
    Biopharm Drug Dispos; 2012 Mar; 33(2):55-71. PubMed ID: 22228149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.